Sat.Aug 03, 2024 - Fri.Aug 09, 2024

article thumbnail

Opinion: Noah Lyles’ collapse with Covid: How not to manage health at the Olympics

STAT

Noah Lyles, a 27-year-old from Gainesville, Florida, has had himself quite an Olympics. He won a gold medal in a photo finish in the 100-meter dash on August 4. He went on to win a bronze medal in the 200-meter dash four days later, then collapsed in a heap and needed a wheelchair to get off the track, suggesting that sports officials and team doctors have put athletes’ health last, not first, during the Paris Olympics.

364
364
article thumbnail

Pharma execs react to final drug price negotiations with Medicare

PharmaVoice

Here’s what the leaders of the companies with the 10 drugs in the first wave of price negotiations with Medicare said about how the new prices will impact their portfolio.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Embracing innovation to drive clinical change in UK stroke care

pharmaphorum

Discover how the innovative geko device is driving clinical change in UK stroke care. Learn how this technology is revolutionising the treatment and management of stroke patients.

131
131
article thumbnail

Roche licenses Sangamo’s technology for another shot at Alzheimer’s drugs

BioPharma Dive

Through a new deal, Roche has exclusive rights to Sangamo molecules designed to repress the gene that makes “tau,” a protein many scientists view as a main driver of Alzheimer’s.

131
131
article thumbnail

From Payroll Pains to Growth Gains: Streamlining Payroll & HR for Success

Speaker: Joe Sharpe and James Carlson

In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.

article thumbnail

FDA approves EpiPen alternative, a nasal spray for anaphylaxis

STAT

On Friday, the Food and Drug Administration approved the first needle-free treatment for adults and kids with severe allergic reactions. The approval introduces a competitor from ARS Pharma to older epinephrine products, like the EpiPen. Neffy, as the product is called, is a nasal spray that delivers the same drug used to treat anaphylaxis. It is ARS’ flagship product.

article thumbnail

Pharmacists eligible for Covid vaccination, government confirms

The Pharmacist

NHS Covid-19 vaccinations will be offered to 'frontline health and social care staff', including pharmacists and staff and volunteers working on the Covid-19 vaccination service, the government has confirmed. And patients aged over 65, care home residents and patients who are pregnant or in a clinical at-risk group will be eligible for the autumn booster, […] The post Pharmacists eligible for Covid vaccination, government confirms appeared first on The Pharmacist.

Vaccines 114

More Trending

article thumbnail

In tone-setting verdict, FDA rejects MDMA as a therapy aid for PTSD

BioPharma Dive

The decision to turn down an application from Lykos Therapeutics comes at a pivotal time for psychedelics research, which, after decades of dismissal, has recently gained momentum.

126
126
article thumbnail

CDC slightly increases risk bird flu could cause a pandemic in latest assessment

STAT

The Centers for Disease Control and Prevention issued a new risk assessment of the H5N1 bird flu virus circulating in dairy cows on Friday, increasing slightly its estimate of the chance it poses of triggering a pandemic. The new assessment , developed using the CDC’s influenza risk assessment tool or IRAT, gauged the risk the virus might someday cause a pandemic at 5.79, up from a previous score of 5.12 from an assessment of a related virus conducted in April 2023.

363
363
article thumbnail

Pharmacies can play a vital role in encouraging blood donations

The Pharmacist

The shortage of blood stocks, particularly group O red cells, remains acute, and the NHS’s amber alert remains in place. Pharmacies have a role to play in encouraging more blood donors, says Dr Avinash Hari Narayanan, clinical lead at the London Medical Laboratory The NHS continues to appeal for people with O-type blood to donate, […] The post Pharmacies can play a vital role in encouraging blood donations appeared first on The Pharmacist.

113
113
article thumbnail

Harnessing genetics to propel cancer research and clinical success

pharmaphorum

Discover how Step Pharma is harnessing genetics and developing therapeutics targeting CTPS1 to advance cancer research and enhance clinical success. Learn more about their innovative approach.

119
119
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

With pharma in ‘catbird seat,’ biotechs get less upfront in drug partnerships

BioPharma Dive

Recent data from J.P. Morgan indicates early-stage startups are getting smaller upfront payments in alliances than a few years ago, a trend industry insiders attribute to weaker leverage in deal talks.

128
128
article thumbnail

FDA rejects MDMA as a psychedelic treatment for PTSD

STAT

The Food and Drug Administration rejected MDMA as a treatment for post-traumatic stress disorder on Friday, in a blow to drug activists and veterans who’ve long campaigned for the psychedelic treatment. Although two Phase 3 trials suggested the treatment was effective, strong opposition by an agency scientific advisory committee in June and allegations of missing adverse event data and research bias may have doomed the application by Lykos Therapeutics.

363
363
article thumbnail

Study reveals AI insights can predict development of disease a decade in advance

Pharma Times

The study predicted the development of conditions including Alzheimer’s and heart disease

Diabetes 148
article thumbnail

AI in the medical devices sector: Fostering innovation while navigating evolving regulations

pharmaphorum

Explore how artificial intelligence and machine learning are revolutionising the medical devices sector. Learn about the innovative technologies and how companies are navigating evolving regulations in this rapidly advancing field.

114
114
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Biotech Red Queen launches with $55M to build versatile antivirals

BioPharma Dive

The funding from Apple Tree Partners will help the startup advance an antiviral drug pipeline that includes a COVID treatment nearing mid-stage testing.

131
131
article thumbnail

STAT+: How UnitedHealth turned a questionable artery-screening program into a gold mine

STAT

The nation’s largest health care company pressed thousands of its clinicians to use a thinly tested medical device to screen people for artery disease, dramatically boosting payments from the federal government for years even though many of the patients were not sick, a STAT investigation found. The result was a torrent of sometimes questionable diagnoses of peripheral artery disease.

364
364
article thumbnail

Sangamo Therapeutics and Genentech team up to develop genomic medicines for neurodegenerative diseases

Pharmafile

Genomic medicine company Sangamo Therapeutics and Genentech have entered into a licensing agreement to develop intravenously administered genomic medicines to treat neurodegenerative diseases. Sangamo is expected to receive $50m in near-term upfront license fees and milestone payments after granting Genentech exclusive licensing for its proprietary zinc finger repressors – that are directed to the tau […] The post Sangamo Therapeutics and Genentech team up to develop genomic medicines for

111
111
article thumbnail

How to harmonise global content strategies with local needs in the pharmaceutical market

pharmaphorum

Learn how to effectively harmonise global content strategies with local needs in the pharmaceutical market. Understand the unique challenges in the life science industry and how to measure success with relevant KPIs.

115
115
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Lilly boosts outlook on rising Zepbound revenue

BioPharma Dive

Sales of the in-demand obesity drug crested $1 billion in the second quarter as improved Lilly production helped the company fulfill wholesaler backorders.

117
117
article thumbnail

As Covid deaths drop, heart disease and cancer remain leading causes of death

STAT

Since its emergence in 2020, Covid has jumbled the list of the 10 leading causes of deaths in the United States. It roared into third place in 2020 but has now fallen to 10th place, the National Center for Health Statistics reported Thursday.  Heart disease and cancer remained the first and second leading causes of death, followed by unintentional injuries as No. 3.

363
363
article thumbnail

Johnson & Johnson’s MedTech announce orthopaedics receives 501K clearance from FDA for spinal robotics and navigation platform

Pharmafile

Today, the Orthopaedics branch of Johnson & Johnson MedTech, DePuy Synthes, has announced that their surgical robotics system VELYS active has received 501k clearance from the US Food and Drug Administration (FDA). The post Johnson & Johnson’s MedTech announce orthopaedics receives 501K clearance from FDA for spinal robotics and navigation platform appeared first on Pharmafile.

111
111
article thumbnail

Minutes to answers: Compliant chat builds more meaningful HCP relationships

pharmaphorum

Compliant chat ensures that Healthcare Professionals (HCPs) receive accurate information in a timely manner, fostering more meaningful relationships. Learn how to navigate compliance in your interactions with HCPs.

110
110
article thumbnail

Zepbound shortages ease, but Lilly cautions pharmacy availability may remain ‘choppy’

BioPharma Dive

After months of supply strains, Lilly has begun to catch up with demand. Consumers may still need to wait for their prescriptions to be filled, however.

117
117
article thumbnail

Harris’ reported running mate, Minnesota Governor Tim Walz, boasts progressive health care record

STAT

WASHINGTON — With Minnesota Gov. Tim Walz as her running mate, Vice President Kamala Harris has tapped a fiery advocate for public health and abortion rights. Harris is said to have chosen Walz as her vice presidential pick as of Tuesday morning, according to multiple news reports, and is expected to officially announce Walz at a rally in Philadelphia, Penn., on Tuesday evening.

article thumbnail

Another baby dies from whooping cough as cases surpass 10,000

The Pharmacist

A further baby died from whooping cough in England in June, bringing the total to 10 since the start of the latest outbreak in November last year. New data published today by the UK Health Security Agency (UKHSA) also revealed laboratory confirmed cases during the outbreak has now surpassed 10,000. In response, UKHSA reiterated advice […] The post Another baby dies from whooping cough as cases surpass 10,000 appeared first on The Pharmacist.

Vaccines 106
article thumbnail

You’re trusted less than a waiter and more than a pilot, but why?

pharmaphorum

Discover why pharmaceutical companies are trusted less than a waiter, but more than a pilot, and explore the role of Patient Advocacy Groups (PAGs) in shaping trust in the pharmaceutical industry.

article thumbnail

Novo shares tumble on lower-than-expected obesity drug sales

BioPharma Dive

Quarterly revenue from Ozempic and Wegovy missed Wall Street estimates by about 9%, concerning some analysts and causing a stock sell-off costing the Danish drugmaker tens of billions in market value.

107
107
article thumbnail

Scientists are starting to uncover how neighborhood can affect the biology of cancer

STAT

Where you live has a relationship to your odds of getting cancer and surviving cancer. Epidemiologists studying this link they see in the data have focused on so-called social determinants of health — poor access to transportation, for example, could make it harder for residents to see a doctor. Places lacking grocery stores with fresh food could mean worse nutrition for locals.

article thumbnail

A Breadcrumb of Serialized Data

Pharmaceutical Commerce

In this part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ Senior Director of DSCSA/Serialization Compliance Services, discusses the state of affairs surrounding the Drug Supply Chain Security Act, along with opportunities for improvement.

105
105
article thumbnail

BMS ducks out of $1.56bn TIGIT alliance with Agenus

pharmaphorum

Bristol-Myers Squibb has handed back rights to a TIGIT drug partnered with Agenus, ending an alliance that could have been worth up to $1.56 billion to the biotech.Agenus revealed BMS' decision in a Securities & Exchange Commission (SEC) filing (PDF), saying it was a result of a "broader strategic realignment of their development pipeline which involves other licensed products.

111
111
article thumbnail

Amgen talks obesity drug ‘differentiation’; Servier brain cancer drug approved by FDA

BioPharma Dive

Executives at Amgen had few updates on their drug MariTide, but defended what they see as the once-monthly shot’s competitive profile.

120
120
article thumbnail

Opinion: Diversity statements should not be required for federal STEMM grant funding

STAT

Federally funded research in science, technology, engineering, mathematics, and medicine (STEMM) is a crown jewel of American higher education that confers enormous benefits upon the U.S. and the world. The integrity of the processes by which funding decisions are made is critically important to the success of the enterprise and its support by the public who pay for this research.

article thumbnail

New Real-World Data Published in Journal of Cardiac Failure on Effectiveness

Pharmafile

Patients treated with tafamidis were associated with greater rates of survival compared with patients untreated with tafamidis. Walton Oaks, 6th August 2024 – Pfizer Ltd today announced publication of real-world results from a cohort of the longitudinal, observational Phase 4 THAOS (Transthyretin Amyloidosis Outcomes Survey) study evaluating survival rates among patients with transthyretin cardiac amyloidosis (ATTR-CM) treated […] The post New Real-World Data Published in Journal of Cardia

105
105